[1]
“Development of CL184 human monoclonal antibody combination for rabies post-exposure prophylaxis, from preclinical design to clinical evaluation”, Rev. Educ. Cont. Med. Vet. Zootec., vol. 10, nº 2/3, p. 45–45, ago. 2013, Acesso em: 5º de dezembro de 2025. [Online]. Disponível em: https://revistamvez-crmvsp.com.br/index.php/recmvz/article/view/249